Nephroferol (Iron Sucrose)

Iron sucrose, the active ingredient in Nephroferol, is an iron preparation presented as an intravenous solution for intravenous use. It treats iron deficiency anemia and anemia of chronic kidney disease by replenishing depleted iron stores. GNH USA supplies Nephroferol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Nephroferol is used to correct iron deficiency in conditions where oral iron is ineffective or not tolerated. - Iron deficiency anemia: restores hemoglobin levels and improves symptoms of fatigue. - Anemia of chronic kidney disease: replenishes iron stores to support erythropoiesis in dialysis and non‑dialysis patients. - Patients receiving erythropoiesis‑stimulating agents: enhances response to therapy by providing necessary iron for red blood cell production.

Common Side Effects: - Nausea: mild to moderate upset stomach after infusion. - Headache: transient headache during or after administration. - Muscle cramps: occasional cramping of limbs. - Hypotension: temporary drop in blood pressure during infusion. - Injection site pain: local discomfort at the IV site. - Metallic taste: brief metallic sensation in the mouth.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe hypotension: marked blood pressure decline needing intervention. - Iron overload: excessive iron accumulation with long‑term use. - Cardiac arrest: rare but life‑threatening event. - Acute respiratory distress: sudden breathing difficulty. - Serum sickness-like reaction: fever, rash, and joint pain.

Nephroferol should be administered under medical supervision with appropriate monitoring. - Monitor iron parameters: check ferritin and transferrin saturation before and during therapy. - Assess for hypersensitivity: discontinue if signs of allergic reaction appear. - Use caution in cardiac disease: watch for hypotension and arrhythmias. - Avoid in active infection: iron can promote bacterial growth. - Administer by trained personnel: ensure proper IV technique and infusion rate. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Nephroferol may interact with other agents that affect iron metabolism or cardiovascular status. Major Interactions (Avoid): - Concurrent IV iron products: risk of iron overload. - High‑dose parenteral vitamin C: increases free iron and oxidative stress. - Certain antihypertensives: may exacerbate hypotension during infusion. Moderate Interactions (Monitor Closely): - Erythropoiesis‑stimulating agents: may require dose adjustment of iron. - Oral phosphate binders: can reduce iron absorption if given simultaneously.